Literature DB >> 2411589

Pulmonary responses to bleomycin-induced injury: an immunomorphologic and electron microscopic study.

R K Kumar, S G Watkins, A W Lykke.   

Abstract

Intratracheal injection of a small dose of bleomycin in rats induced early alveolar epithelial cell injury and a pneumonitis which subsequently evolved to pulmonary fibrosis. Hydropic degeneration of type I pneumocytes was apparent at 3 days after treatment. Marked interstitial and intra-alveolar pneumonitis developed at 7 days after treatment and was accompanied by hypertrophy and hyperplasia of type II pneumocytes. The inflammatory cell population consisted predominantly of cells with the morphology of large lymphocytes together with a number of eosinophils. Examination by immunoperoxidase and histochemical staining of frozen sections revealed that the lymphoid cells stained positively with the monoclonal antibodies W3/13 and W3/25 but not with other markers. Thus these cells appeared to be helper T lymphocytes. The later development of interstitial fibrosis was accompanied by alveolar microcollapse which contributed to the thickening of alveolar septa observed by light microscopy. The possible role of immunologic and other mechanisms in the pathogenesis of bleomycin-induced pulmonary fibrosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411589     DOI: 10.1016/s0232-1513(85)80030-x

Source DB:  PubMed          Journal:  Exp Pathol        ISSN: 0232-1513


  5 in total

1.  FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice.

Authors:  S Yara; K Kawakami; N Kudeken; M Tohyama; K Teruya; T Chinen; A Awaya; A Saito
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica.

Authors:  R K Kumar
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

3.  Immunohistochemical identification of type 2 pneumocytes by an antibody to a lamellar body-enriched fraction of lung homogenate.

Authors:  R K Kumar; A W Lykke; J Y Truscott; S G Watkins; G J Smith
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 4.  Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants.

Authors:  B E Miller; G E Hook
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

Review 5.  Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Authors:  Kai Wang; Qing Ju; Jing Cao; Wenze Tang; Jian Zhang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.